company

HERNESMOEN BIOBRENSEL AS

2116 SANDER

Return on Equity
20,7 %
Current Ratio
0,76
Debt-to-Equity Ratio
0,7
Key figures (NOK)2022
Revenue1 040 000
Net Income437 000
Total Assets3 972 000
Total Equity2 111 000
Income (NOK)2022
Revenue1 040 000
Expenditure374 000
Operating Profit665 000
Financial Income0
Financial Costs76 000
Financial Balance−76 000
Earnings Before Tax589 000
Tax152 000
Net Income437 000
Balance (NOK)2022
Total Fixed Assets3 687 000
Total Current Assets285 000
Total Assets3 972 000
Total Retained Equity2 081 000
Total Equity2 111 000
Total Long-Term Debt1 487 000
Total Current Debt373 000
Total Equity and Debt3 972 000
Cash flow (NOK)2022
Sales Income1 040 000
Other Income0
Revenue1 040 000
Cost of Goods Sold0
Salary Costs0
Depreciation254 000
Impairment0
Expenditure374 000
Operating Profit665 000
Financial Income0
Financial Costs76 000
Financial Balance−76 000
Dividends0
Net Income437 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate3 687 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets3 687 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 687 000
Stock0
Total Investments0
Cash, Bank274 000
Total Current Assets285 000
Total Assets3 972 000
Total Equity2 111 000
Short-Term Group Debt0
Total Long-Term Debt1 487 000
Creditors15 000
Unpaid Taxes39 000
Dividends0
Other Current Debt168 000
Total Current Debt373 000
Total Equity and Debt3 972 000
Financial indicators2022
Return on Equity20,7 %
Debt-to-Equity Ratio0,7
Operating Profit Margin63,94 %
Current Ratio0,76
Quick Ratio0,76
Equity Ratio0,53
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English